IL1B and rheumatoid arthritis: Activation of the FcεRI and FcγRs receptors of MCs can cause the release of various pro-inflammatory compounds, including IL-1, which contributes to chronic inflammation (as, for example, occurs in rheumatoid arthritis) [16].